期刊文献+

腹腔化疗对老年结直肠癌病人手术后细胞免疫功能的影响 被引量:6

Effect of Intraperitoneal Chemotherapy on Immune Function in Elderly Patients with Colorectal Cancer After Radical Operation
下载PDF
导出
摘要 目的:探讨老年结直肠癌病人手术后腹腔化疗对免疫状况的影响。方法:对1998年1月至2 0 0 2年12月6 0岁以上行根治性手术的5 2例结直肠癌病人进行腹腔化疗前后细胞免疫检测,并将之与我院同期健康老年对照组和行静脉化疗病例进行比较。所有病人于化疗前1d和化疗后1周早晨空腹时静脉采血,测定血清中NK细胞和T细胞亚群。结果:老年结直肠癌病人手术后CD4 + 和NK细胞水平明显低于健康老年人群;老年结直肠癌病人化疗后CD4 + 、CD4 + /CD8+ 和NK细胞水平低于化疗前,其中静脉化疗病人化疗后较化疗前明显降低,存在统计学意义(P <0 .0 5 ) ;而腹腔化疗组病人化疗前后上述指标的变化不大,无统计学意义(P >0 .0 5 )。结论:针对老年病人的免疫特点,采用细胞免疫抑制较轻的腹腔化疗方式进行化疗,对老年结直肠癌病人有一定的临床价值。 Objective: To investigate the effect of intraperitoneal chemotherapy on immune function in elderly patients with colorectal cancer after radical operation. Methods:From Jan. 1998 to Dec. 2002, NK cell and T cell subgroup of 52 elderly patients with colorectal cancer were measured 1 day before and 7 days after intraperitoneal chemotherapy. The results were analyzed with those of normal old people and those of intravenous chemotherapy. Results: The levels of CD4^+,CD4^+/CD8^+and NK cell were lower in elderly patients with colorectal cancer than those of the normal old people. The levels of CD4^+ ,CD4^+/CD8^+ and NK cell decreased in elderly patients with colorectal cancer after intravenous chemotherapy and had no distinct change after intraperitoneal chemotherapy. Conclusion:It is essential to treat elderly patients with colorectal cancer after operation with intraperitoneal chemotherapy, which has less cellular immune damage.
出处 《大肠肛门病外科杂志》 2005年第1期13-15,共3页 Journal of Coloproctological Surgery
关键词 结直肠癌 腹腔化疗 老年病人 细胞免疫 Colorectal cancer Intraperitoneal chemotherapy Elderly patients Cellular immunity
  • 相关文献

参考文献10

  • 1Yu W, Whang I, Chung HY, et al. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial.World J Surg 2001,25 (8): 985-990.
  • 2Elias D,Blot F,El Otmany A,et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.Cancer 2001,92(1): 71-76.
  • 3Ragnhammar P,Hafstrom L,Nygren P,et al. A systema tic overview of chemotherapy effects in colorectal cancer.Acta Oncol,2001,40(2-3):282-308.
  • 4Ilson DH. Adjuvant therapy for noncolorectal cancers.Curr Opin Oncol2001,13(4): 287-290.
  • 5Jansen M, Buchin P,Dreuw B,et al.Prognostic factors for development of peritoneal carcinosis in stomach carcinoma Chirurg,2001,72(5):561-565.
  • 6Ohwada S,Line Y,NaKamura S,et al.Peripheral blood T cell subsets as a prognostic Factor in gastric cancer.Jpn J Clin Oncol,1994,24:7.
  • 7Saji S,Kunieda K,Sugiyama Y,et al. Immunochemotherapy for cancer patients of the stomach-cancer therapy keeping with good host-immunocompetency. Nippon Rinsho, 2001, 59(4): 420-426.
  • 8Jackson PA, Green MA, Marks CG, et al.Lymphocyte subset infiltration patterns and antigen status in colorectal carcinomas and adenomas.Gut,1996,38(1):85.
  • 9Herhman MJ,Cheadle WG,Wellhausen SR,et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient.Br Jsurg,1990,77:204.
  • 10Takeuchi H,Maehara Y,Tokunaga E,et al. Prognostic significance of natural killer cell activity in patients with gastric carcinoma:a multivariate analysis. Am J Gastroenterol.2001,96(2):574-578.

同被引文献42

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部